Review



pan vegf capture antibody  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 95
      Buy from Supplier

    Structured Review

    R&D Systems pan vegf capture antibody
    Pan Vegf Capture Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 800 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pan+vegf+capture+antibody/VEGF+Antibody+(VEGFA%2F7635R)/us10301264-262-2-9
    Average 95 stars, based on 800 article reviews
    pan vegf capture antibody - by Bioz Stars, 2026-10
    95/100 stars

    Images

    Related Articles

    Enzyme-linked Immunosorbent Assay:

    Article Title: WT1 mutants reveal SRPK1 to be a downstream angiogenesis target by altering VEGF splicing
    Article Snippet: .. A pan-VEGF capture antibody (Duoset VEGF ELISA DY-293; R&D systems) and recombinant human VEGF 165 or VEGF 165 b standards were used. .. Biotinylated goat anti-human VEGF (0.025 μg/ml; R&D systems) or mouse anti-human VEGF 165 b (clone 264610/1, 0.025 μg/ml, R&D systems) were used as detection antibodies.

    Article Title: VEGF165b, an Inhibitory Vascular Endothelial Growth Factor Splice Variant
    Article Snippet: .. A total of 0.8 g/mL pan-VEGF capture antibody (Duoset VEGF ELISA DY-293; R&D Systems) diluted in 1 PBS (pH 7.4) was adsorbed onto 96-well sterile plates (655161; Greiner Bio-one Ltd., Gloucester, United Kingdom) overnight at room temperature (100 L/well). ..

    Article Title: WT1 mutants reveal SRPK1 to be a downstream angiogenesis target by altering VEGF splicing
    Article Snippet: .. ELISA A pan-VEGF capture antibody (Duoset VEGF ELISA DY-293; R&D systems) and recombinant human VEGF 165 or VEGF 165 b standards were used. .. Biotinylated goat anti-human VEGF (0.025 μg/ml; R&D systems) or mouse anti-human VEGF 165 b (clone 264610/1, 0.025 μg/ml, R&D systems) were used as detection antibodies.

    Article Title: SRPK1 inhibition modulates VEGF splicing to reduce pathological neovascularisation in a rat model of Retinopathy of Prematurity
    Article Snippet: .. PanVEGF and VEGF xxx b enzyme-linked immunosorbent assay (ELISA) One μg/ml pan-VEGF capture antibody (Duoset VEGF ELISA DY-293; R&D systems) was incubated overnight at room temperature. .. The plates were blocked (Superblock; Thermo Scientific) and serial dilutions of recombinant human (rh)VEGF 165 or rhVEGF 165 b standards (ranging from 4ng/ml to 16.25pg/ml) were added, incubated alongside sample lysates, typically diluted 1:10.

    Recombinant:

    Article Title: WT1 mutants reveal SRPK1 to be a downstream angiogenesis target by altering VEGF splicing
    Article Snippet: .. A pan-VEGF capture antibody (Duoset VEGF ELISA DY-293; R&D systems) and recombinant human VEGF 165 or VEGF 165 b standards were used. .. Biotinylated goat anti-human VEGF (0.025 μg/ml; R&D systems) or mouse anti-human VEGF 165 b (clone 264610/1, 0.025 μg/ml, R&D systems) were used as detection antibodies.

    Article Title: WT1 mutants reveal SRPK1 to be a downstream angiogenesis target by altering VEGF splicing
    Article Snippet: .. ELISA A pan-VEGF capture antibody (Duoset VEGF ELISA DY-293; R&D systems) and recombinant human VEGF 165 or VEGF 165 b standards were used. .. Biotinylated goat anti-human VEGF (0.025 μg/ml; R&D systems) or mouse anti-human VEGF 165 b (clone 264610/1, 0.025 μg/ml, R&D systems) were used as detection antibodies.

    other:

    Article Title: Compounds useful for treating ocular neovasculan
    Article Snippet: The plates were blocked (Superblock; Thermo Scientific) and serial dilutions of recombinant human (rh)VEGF165 or rhVEGF165b standards (ranging from 4 ng/ml to 16.25 pg/ml) were added, incubated alongside sample lysates, typically diluted 1:10.

    Sterility:

    Article Title: VEGF165b, an Inhibitory Vascular Endothelial Growth Factor Splice Variant
    Article Snippet: .. A total of 0.8 g/mL pan-VEGF capture antibody (Duoset VEGF ELISA DY-293; R&D Systems) diluted in 1 PBS (pH 7.4) was adsorbed onto 96-well sterile plates (655161; Greiner Bio-one Ltd., Gloucester, United Kingdom) overnight at room temperature (100 L/well). ..

    Incubation:

    Article Title: SRPK1 inhibition modulates VEGF splicing to reduce pathological neovascularisation in a rat model of Retinopathy of Prematurity
    Article Snippet: .. PanVEGF and VEGF xxx b enzyme-linked immunosorbent assay (ELISA) One μg/ml pan-VEGF capture antibody (Duoset VEGF ELISA DY-293; R&D systems) was incubated overnight at room temperature. .. The plates were blocked (Superblock; Thermo Scientific) and serial dilutions of recombinant human (rh)VEGF 165 or rhVEGF 165 b standards (ranging from 4ng/ml to 16.25pg/ml) were added, incubated alongside sample lysates, typically diluted 1:10.



    Similar Products

    pan vegf capture antibody  (R&D Systems)
    95
    R&D Systems pan vegf capture antibody
    Pan Vegf Capture Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pan+vegf+capture+antibody/VEGF+Antibody+(VEGFA%2F7635R)/us10301264-262-2-9
    Average 95 stars, based on 1 article reviews
    pan vegf capture antibody - by Bioz Stars, 2026-10
    95/100 stars
    		  Buy from Supplier
    pan-vegf capture antibody  (R&D Systems)
    90
    R&D Systems pan-vegf capture antibody
    Effect of SRPK1 inhibitors on <t>VEGF</t> and SR protein phosphorylation. (A) ARPE-19 cells were treated with 10 μM SRPIN340, MVRL09, SPHINX, or left untreated, and subsequently either treated or not with EGF. Extracted protein was run on Western blots for phospho-SR proteins. (A) Bands were observed at molecular weights corresponding to SRSF1/2, SRSF4, and SRSF6, densitometry analysis was undertaken on SRSF1/2. SRPK inhibition significantly reduced the endogenous phosphorylation of SRSF1/2, moreover pre-incubation of cells with either SRPIN340 or SPHINX significantly blocked an EGF-induced increase in SR protein phosphorylation. (B) Serum-starved primary RPE cells and ARPE-19 cells were treated with inhibitors at 5 μM. Twenty-four hours later, RNA was extracted and cDNA was made. PCR was performed with primers spanning VEGF exon 7b and 8b. Treatment with the inhibitors reduced the expression of VEGF165 relative to GAPDH control either in primary RPE cells (SRPIN340) or both cell lines (SPHINX and MVRL09). Water (W) and sample without RT were used as negative controls. (C) Forty-eight hours after treatment, protein was extracted and assayed for total VEGF <t>by</t> <t>ELISA.</t> Protein was assessed using a VEGFxxxb-specific ELISA and the ratio of VEGFxxxb over total VEGF calculated. The ratio increased in ARPE-19 during treatment with SPHINX and SRPIN340, and in primary RPE during treatment with SPHINX and MVRL09. Total VEGF expression relative to total protein was also calculated. In primary RPE, VEGF expression was reduced following SRPIN340 and MVRL09 treatment, in ARPE-19, VEGF expression was increased following SPHINX and MVRL09 treatment (One-way ANOVA, Bonferroni post hoc. *P < 0.05, **P < 0.01).
    Pan Vegf Capture Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pan+vegf+capture+antibody/vegf+neutralizing+antibody/pmc03771558-98-3-11
    Average 90 stars, based on 1 article reviews
    pan-vegf capture antibody - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    pan vegf mouse capture antibody  (R&D Systems)
    92
    R&D Systems pan vegf mouse capture antibody
    Effect of SRPK1 inhibitors on <t>VEGF</t> and SR protein phosphorylation. (A) ARPE-19 cells were treated with 10 μM SRPIN340, MVRL09, SPHINX, or left untreated, and subsequently either treated or not with EGF. Extracted protein was run on Western blots for phospho-SR proteins. (A) Bands were observed at molecular weights corresponding to SRSF1/2, SRSF4, and SRSF6, densitometry analysis was undertaken on SRSF1/2. SRPK inhibition significantly reduced the endogenous phosphorylation of SRSF1/2, moreover pre-incubation of cells with either SRPIN340 or SPHINX significantly blocked an EGF-induced increase in SR protein phosphorylation. (B) Serum-starved primary RPE cells and ARPE-19 cells were treated with inhibitors at 5 μM. Twenty-four hours later, RNA was extracted and cDNA was made. PCR was performed with primers spanning VEGF exon 7b and 8b. Treatment with the inhibitors reduced the expression of VEGF165 relative to GAPDH control either in primary RPE cells (SRPIN340) or both cell lines (SPHINX and MVRL09). Water (W) and sample without RT were used as negative controls. (C) Forty-eight hours after treatment, protein was extracted and assayed for total VEGF <t>by</t> <t>ELISA.</t> Protein was assessed using a VEGFxxxb-specific ELISA and the ratio of VEGFxxxb over total VEGF calculated. The ratio increased in ARPE-19 during treatment with SPHINX and SRPIN340, and in primary RPE during treatment with SPHINX and MVRL09. Total VEGF expression relative to total protein was also calculated. In primary RPE, VEGF expression was reduced following SRPIN340 and MVRL09 treatment, in ARPE-19, VEGF expression was increased following SPHINX and MVRL09 treatment (One-way ANOVA, Bonferroni post hoc. *P < 0.05, **P < 0.01).
    Pan Vegf Mouse Capture Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pan+vegf+capture+antibody/Mouse+VEGF-D+Antibody/pmc02361696-36-0-11
    Average 92 stars, based on 1 article reviews
    pan vegf mouse capture antibody - by Bioz Stars, 2026-10
    92/100 stars
    		  Buy from Supplier
    vegfxxxb elisa goat anti-(human pan-vegf) capture antibody  (R&D Systems)
    90
    R&D Systems vegfxxxb elisa goat anti-(human pan-vegf) capture antibody
    Effect of SRPK1 inhibitors on <t>VEGF</t> and SR protein phosphorylation. (A) ARPE-19 cells were treated with 10 μM SRPIN340, MVRL09, SPHINX, or left untreated, and subsequently either treated or not with EGF. Extracted protein was run on Western blots for phospho-SR proteins. (A) Bands were observed at molecular weights corresponding to SRSF1/2, SRSF4, and SRSF6, densitometry analysis was undertaken on SRSF1/2. SRPK inhibition significantly reduced the endogenous phosphorylation of SRSF1/2, moreover pre-incubation of cells with either SRPIN340 or SPHINX significantly blocked an EGF-induced increase in SR protein phosphorylation. (B) Serum-starved primary RPE cells and ARPE-19 cells were treated with inhibitors at 5 μM. Twenty-four hours later, RNA was extracted and cDNA was made. PCR was performed with primers spanning VEGF exon 7b and 8b. Treatment with the inhibitors reduced the expression of VEGF165 relative to GAPDH control either in primary RPE cells (SRPIN340) or both cell lines (SPHINX and MVRL09). Water (W) and sample without RT were used as negative controls. (C) Forty-eight hours after treatment, protein was extracted and assayed for total VEGF <t>by</t> <t>ELISA.</t> Protein was assessed using a VEGFxxxb-specific ELISA and the ratio of VEGFxxxb over total VEGF calculated. The ratio increased in ARPE-19 during treatment with SPHINX and SRPIN340, and in primary RPE during treatment with SPHINX and MVRL09. Total VEGF expression relative to total protein was also calculated. In primary RPE, VEGF expression was reduced following SRPIN340 and MVRL09 treatment, in ARPE-19, VEGF expression was increased following SPHINX and MVRL09 treatment (One-way ANOVA, Bonferroni post hoc. *P < 0.05, **P < 0.01).
    Vegfxxxb Elisa Goat Anti (Human Pan Vegf) Capture Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pan+vegf+capture+antibody/vegfxxxb+elisa+goat+anti++human+pan+vegf++capture+antibody/pm16451124-103-15-11
    Average 90 stars, based on 1 article reviews
    vegfxxxb elisa goat anti-(human pan-vegf) capture antibody - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Effect of SRPK1 inhibitors on VEGF and SR protein phosphorylation. (A) ARPE-19 cells were treated with 10 μM SRPIN340, MVRL09, SPHINX, or left untreated, and subsequently either treated or not with EGF. Extracted protein was run on Western blots for phospho-SR proteins. (A) Bands were observed at molecular weights corresponding to SRSF1/2, SRSF4, and SRSF6, densitometry analysis was undertaken on SRSF1/2. SRPK inhibition significantly reduced the endogenous phosphorylation of SRSF1/2, moreover pre-incubation of cells with either SRPIN340 or SPHINX significantly blocked an EGF-induced increase in SR protein phosphorylation. (B) Serum-starved primary RPE cells and ARPE-19 cells were treated with inhibitors at 5 μM. Twenty-four hours later, RNA was extracted and cDNA was made. PCR was performed with primers spanning VEGF exon 7b and 8b. Treatment with the inhibitors reduced the expression of VEGF165 relative to GAPDH control either in primary RPE cells (SRPIN340) or both cell lines (SPHINX and MVRL09). Water (W) and sample without RT were used as negative controls. (C) Forty-eight hours after treatment, protein was extracted and assayed for total VEGF by ELISA. Protein was assessed using a VEGFxxxb-specific ELISA and the ratio of VEGFxxxb over total VEGF calculated. The ratio increased in ARPE-19 during treatment with SPHINX and SRPIN340, and in primary RPE during treatment with SPHINX and MVRL09. Total VEGF expression relative to total protein was also calculated. In primary RPE, VEGF expression was reduced following SRPIN340 and MVRL09 treatment, in ARPE-19, VEGF expression was increased following SPHINX and MVRL09 treatment (One-way ANOVA, Bonferroni post hoc. *P < 0.05, **P < 0.01).

    Journal: Investigative Ophthalmology & Visual Science

    Article Title: Topical Antiangiogenic SRPK1 Inhibitors Reduce Choroidal Neovascularization in Rodent Models of Exudative AMD

    doi: 10.1167/iovs.13-12422

    Figure Lengend Snippet: Effect of SRPK1 inhibitors on VEGF and SR protein phosphorylation. (A) ARPE-19 cells were treated with 10 μM SRPIN340, MVRL09, SPHINX, or left untreated, and subsequently either treated or not with EGF. Extracted protein was run on Western blots for phospho-SR proteins. (A) Bands were observed at molecular weights corresponding to SRSF1/2, SRSF4, and SRSF6, densitometry analysis was undertaken on SRSF1/2. SRPK inhibition significantly reduced the endogenous phosphorylation of SRSF1/2, moreover pre-incubation of cells with either SRPIN340 or SPHINX significantly blocked an EGF-induced increase in SR protein phosphorylation. (B) Serum-starved primary RPE cells and ARPE-19 cells were treated with inhibitors at 5 μM. Twenty-four hours later, RNA was extracted and cDNA was made. PCR was performed with primers spanning VEGF exon 7b and 8b. Treatment with the inhibitors reduced the expression of VEGF165 relative to GAPDH control either in primary RPE cells (SRPIN340) or both cell lines (SPHINX and MVRL09). Water (W) and sample without RT were used as negative controls. (C) Forty-eight hours after treatment, protein was extracted and assayed for total VEGF by ELISA. Protein was assessed using a VEGFxxxb-specific ELISA and the ratio of VEGFxxxb over total VEGF calculated. The ratio increased in ARPE-19 during treatment with SPHINX and SRPIN340, and in primary RPE during treatment with SPHINX and MVRL09. Total VEGF expression relative to total protein was also calculated. In primary RPE, VEGF expression was reduced following SRPIN340 and MVRL09 treatment, in ARPE-19, VEGF expression was increased following SPHINX and MVRL09 treatment (One-way ANOVA, Bonferroni post hoc. *P < 0.05, **P < 0.01).

    Article Snippet: One microgram per milliliter pan-VEGF capture antibody (Duoset VEGF ELISA DY-293; R&D Systems, Abingdon, UK) was incubated overnight at room temperature.

    Techniques: Western Blot, Inhibition, Incubation, Expressing, Enzyme-linked Immunosorbent Assay